A Look Back: How Far Clinical Trial Technology Has Come
Driving Clinical Speed and Agility Post-COVID
Sample Size Re-Estimation as an Adaptive Design
Building Relationships Key for Smaller Sponsors
Rebadging Gains Momentum Amidst COVID
The Post-Pandemic CRO Landscape
Amplifying Patient Voices in Protocol Design
The State of IRT and RTSM Technologies
Rhetoric and Realism Colliding on EU Discussions of Drug Repurposing
Could Technology Supplant CROs?
Applied Clinical Trials September 2021 Issue (PDF)
Biosimilars Move to Center Stage